Mirna Therapeutics Secures $1,500,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=43092bbe-ecdf-48e8-b788-86d608b14394&Preview=1
Date
8/23/2011
Company Name
Mirna Therapeutics
Mailing Address
2150 Woodward St. Austin, TX 78744
Company Description
Mirna Therapeutics, Inc., traces its lineage back to Ambion, Inc., a privately held company that offered research reagents for RNA analysis. It was at Ambion where Mirna’s miRNA therapeutic research and development program began in 2002 when the first molecular biology tools were developed for studying miRNAs. Ambion scientists started using these tools themselves to compare the miRNA expression patterns of tumor and normal adjacent tissue.
Website
http://www.mirnatherapeutics.com
Transaction Type
Venture Equity
Transaction Amount
$1,500,000
Transaction Round
Undisclosed
Proceeds Purposes
The proceeds of this financing combined with our significant state funding will continue to support our developmentefforts as we complete our preclinical work towards submitting an IND by the end of 2012.
M&A Terms
Venture Investor
Undisclosed